Work

Abstract PS5-11: Ultrasensitive ctDNA Tracking Predicts Exceptional Response in HER2+ Metastatic Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-11

Institutions: Dana-Farber Cancer Institute, Broad Institute, Yale Cancer Center, Yale University, University of Milan

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129201316

Cites:

Cited by: 2

Related to: